Anna Axelsson Raja

MD, PhD, cardiology fellow | bench-to-bedside in inherited cardiovascular disease @rigsheart @rigshospitalet

[Anna Axelsson Raja @AnnaAxRaja]

Excited to attend the HCM society scientific sessions. Great opportunity to discuss the latest scientific advances in the field of HCM with leading experts and not least to draw on the American experiences in clinical implementation of cardiac myosin inhibitors #HCMS2023

[Copenhagen Baby Heart Study (CBHS) @cphbabyheart]

📢In collaboration with researches from @BostonChildrens we developed normative reference intervals and z-scores for echocardiographic measurements of left ventricular structure and function in healthy newborns.
Read the full article at @JACCJournals🔗👇
https://t.co/I2aLOa9yEt

[Anna Axelsson Raja @AnnaAxRaja]

@ARuwald @drjohnm @TorBiering @CardiologyZuh Time to promote #CROWD-ASPECT Cluster and Registry trials Of the Working group of heart failure in Denmark-Are SPironolacton and Eplerenon Comparable Treatments? 🫀💻 #heartfailure

[Anna Axelsson Raja @AnnaAxRaja]

Flying home from Manchester wiser after attending fantastic #ESHGcardiovasculargenetics2023 Huge thanks to course directors, faculty, presenters and fellow attendees for amazing lectures, workshops and networking 🧬🫀
And who would have dreamed: plenty of sunshine ☀️☀️☀️

[Tia Moscarello @TiaMoscarello]

Please join us for the Spring 2023 Inherited Cardiovascular Disease Seminars. Experts in polygenic risk scores, aortopathies, dilated cardiomyopathy and pediatric genetic heart disease in the line-up over the next month. Wednesdays, 12-1pm PT - hope to see you there!

[Anna Axelsson Raja @AnnaAxRaja]

Congratulations @sday_hcm and all LIVE-HCM investigators on an important study demonstrating that patients with HCM exercising vigorously or competitively do not have a higher risk of death or arrhythmic events compared to those who do not.

[Jonas Egebart @JonasEgebart]

Vi bruger tid & kræfter i @akutberedskabet på at tage os af folk, der har drukket for meget - og faktisk kan du hjælpe! Se Karl fortælle om det her, og del meget gerne videoen. #sundpol #dkpol @RegionH

[Anna Axelsson Raja @AnnaAxRaja]

Spent the afternoon enjoying @ulvedreng excel in Precision Medicine in Inherited Cardiomyopathies. 🫀🧬 #PhDdefence #jobwelldone

[Anna Axelsson Raja @AnnaAxRaja]

@jodieingles27 The famous funnel-web hunter?

[A/Prof Jodie Ingles @jodieingles27]

Oh yay! This is out!! We put together a simple summary of what to know when seeing families after a young sudden cardiac death. High five to the awesome co-authors @LauraYeates1 @pretzeldr Leesa Adlard! ⭐️ @EndUCD_Aus

@GarvanInstitute @GregPage_Yellow @NSWCVRN @heartfoundation

[Anna Axelsson Raja @AnnaAxRaja]

@teRieleA in today’s session ‘State Of The Art: Cardiomyopathy’ arguing why ARVC Risk Stratification in 2022 should include personalized risk assessment 👩🏼‍🦰👦🏽👩🏼‍🦱👨🏾‍🦳or even a
gen- first 🧬approach. #cardiogenetics #AHA22

[Anna Axelsson Raja @AnnaAxRaja]

@IacopoOlivotto presenting contemporary issues in #HCM in today’s session ‘State Of The Art: Cardiomyopathy’
❤️‍🩹25% of HCM patients contracting COVID were hospitalized and 6% were admitted to the ICU
❤️‍🩹in women with HCM, pregnancy was not driving outcome but symptoms were #AHA22

[Anna Axelsson Raja @AnnaAxRaja]

@thiele_holger @hvanspall @AGIKinterv Is clinical practice not the control arm? @CardResearchOuh @cardiac_group
Escalation of therapy as part of the primary endpoint seems problematic.
Eager to see the results from #DANGERschock Hopefully in the near future.

[Holger Thiele @thiele_holger]

No benefit of immediate #ECMO in ECMO-CS trial #AHA2022. Will this change clinical practice? 40% cross-over rate, no venting strategy ⁦@hvanspall⁩ ⁦@AGIKinterv⁩

[Anna Axelsson Raja @AnnaAxRaja]

Excited to join the session ‘State Of The Art: Cardiomyopathy’🧬🫀as #SoMe moderator this afternoon 3.30-4.30 pm. If in Chicago and interested in #cardiogenetics don’t miss out ❗️@IacopoOlivotto, @CarolynHoMD Kricket Seidman @stephaneheymans @teRieleA, S Ware, @Arbu_stiniE #AHA

[Anna Axelsson Raja @AnnaAxRaja]

Catching up with old friends #aha22

[Anna Axelsson Raja @AnnaAxRaja]

Impressed by the results of in-vivo #CRISPR #geneediting in patients with ATTR cardiac #amyloidosis corroborating previous results from patients with ATTR polyneuropathy. 🧬🫀 Congratulations to Julian Gillmore et al❗️#AHA22 #cardiogenetics

[Anna Axelsson Raja @AnnaAxRaja]

Privileged to participate in the Wittek research foundation hypertrophic cardiomyopathy think tank meeting #outlinethefuture in #cardiogenetics #researchpriorities
@AHA22 @wittekHCM @CarolynHoMD

[Anna Axelsson Raja @AnnaAxRaja]

Attending #AHA22 and interested in #cardiomyopathy #cardiogenetics❓ Join us for ‘State Of The Art: Cardiomyopathy’ Nov 6, 3:30-4:30. Cutting edge topics in cardiomyopathy 🧬🫀
@IacopoOlivotto, Dr Ho and Dr Seidman @BrighamWomens @stephaneheymans @teRieleA, S Ware, @Arbu_stiniE

[Anna Axelsson Raja @AnnaAxRaja]

On my way to Aalborg to get wiser on #omics
Fra omics til personlig medicin 🧬
#mastersprogrammeinpersonalisedmedicine
@koebenhavns_uni @aalborg_uni @SisseOstrowski
https://t.co/UM7Yp2xnzQ